@article{cb44c71344ef42a8b3f56f87ded81546,
title = "Uncoupling vaccination from politics: a call to action",
author = "{Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA} and Sharfstein, {Joshua M.} and Timothy Callaghan and Carpiano, {Richard M.} and Sgaier, {Sema K.} and Brewer, {Noel T.} and Galvani, {Alison P.} and Rekha Lakshmanan and McFadden, {Sarah Ann M.} and Reiss, {Dorit R.} and Salmon, {Daniel A.} and Hotez, {Peter J.}",
note = "Funding Information: The Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA is co-hosted by the Yale Institute for Global Health and the Baylor College of Medicine. JMS has served as a health official in Democratic administrations at the state, local, and federal level. RMC has received research grant funding from Novo Nordisk Foundation (Denmark). RL reports grants from Pfizer, GlaxoSmithKline, SanofiPasteur, and Merck, and personal fees from BIO. DRR's family own stocks in GlaxoSmithKline, and she served in an unpaid, volunteer capacity on Moderna's ethics allocation committee. DAS reports grants from Merck, personal fees from Pfizer, and consultant for Janssen. PJH is a developer of a COVID-19 vaccine construct, which was licensed by Baylor College of Medicine to Biological E, a commercial vaccine manufacturer. The other authors declare no competing interests.",
year = "2021",
month = oct,
day = "2",
doi = "10.1016/S0140-6736(21)02099-7",
language = "English (US)",
volume = "398",
pages = "1211--1212",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10307",
}